Efthymios N. Deliargyris

Showing 1-4 of 4 articles

Short- and long-term mortality following bleeding events in patients undergoing percutaneous coronary intervention: insights from four validated bleeding scales in the CHAMPION trials

Vaduganathan M, Harrington R, Stone G, Steg P, Gibson M, Hamm C, Price M, Lopes R, Leonardi S, Deliargyris E, Prats J, Mahaffey K, White H, Bhatt D

February 2, 2018 | 10.4244/EIJ-D-17-00723

Coronary interventions

Bivalirudin infusion to reduce ventricular infarction: the open-label, randomised Bivalirudin Infusion for Ventricular InfArction Limitation (BIVAL) study

van Geuns R, Sideris G, van Royen N, El Mahmoud R, Diletti R, Sollier C, Garot J, Van Der Hoeven N, Cortese B, Ding L, Lechthaler I, Deliargyris E, Anthopoulos P, Drouet L

August 4, 2017 | 10.4244/EIJ-D-17-00307

Impact of antithrombotic treatment on short-term outcomes after percutaneous coronary intervention for left main disease: a pooled analysis from REPLACE-2, ACUITY, and HORIZONS-AMI trials

Geisler T, Müller K, Karathanos A, Bocksch W, Gawaz M, Deliargyris E, Bernstein D, Lincoff A, Mehran R, Dangas G, Stone G

May 20, 2014 | 10.4244/EIJV10I1A16

Bivalirudin versus unfractionated heparin in percutaneous coronary interventions of patients having received initial fondaparinux treatment: a propensity matched study

Hamon M, Rao S, Steg G, Valgimigli M, Verheugt F, Marso S, Gershlick A, Wang Y, Deliargyris E

August 24, 2012 | 10.4244/EIJV8I4A76

1

Latest news

A State-of-the Art and Mini Focus on Intracoronary OCT; Thrombectomy for Acute Ischaemic Stroke; and more…

Intracoronary OCT: State of the Art and Future Directions

Ziad A. Ali et al.

PCR Companion attending EuroPCR? Activate your free subscription!

Access the full Trials Book 2021

(Thanks to the support of Biotronik)

This Week's JAA's: ABSORB DAPT, OFR in predicting post-PCI FFR and more...

Joint EAPCI/ACVC expert consensus on pVADs

Alaide Chieffo et al.

New JAA's: Impact of HPR on clopidogrel monotherapy and more...

Valvular disease